The use of opioids in the last week of life in an acute palliative care unit

American Journal of Hospice and Palliative Medicine

Volumn 27, Issue 8, 2010, Pages 514-517

  Mercadante, Sebastiano ^a   Ferrera, Patrizia ^b   Casuccio, Alessandra ^b  

^a LA MADDALENA CANCER CENTER   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

end of life; intravenous morphine; opioids

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

AGED; ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG UTILIZATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ITALY; MALE; MIDDLE AGED; NEOPLASM; PALLIATIVE THERAPY; TERMINAL CARE;

AGED; ANALGESICS, OPIOID; DRUG ADMINISTRATION ROUTES; DRUG UTILIZATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; ITALY; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PALLIATIVE CARE; TERMINAL CARE;

EID: 78249248093     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909110366010     Document Type: Article

References (23)

1. Portenoy RK, Sibirceva U., Smout R.,et al.Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Manage. 2006;32(6):532-540.
2. Morita T., Tsunoma J., Inoue S., Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage. 2001;21(4):282-289.
3. Thorns A., Sykes N. Opioid use in the last week of life and implications for end-of-life decision-making. Lancet. 2000;356(9227): 398-399.
4. Coyle N., Adelhardt J., Foley KM, Portenoy RK Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage. 1990;5(2):83-93.
5. Fainsinger RL, Waller A., Bercovich M.,et al.A muticentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med. 2000;14(4):257-265.
6. Mercadante S., Casuccio A., Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage. 2000;20(2):104-112.
7. Ellershaw J., Gambles M., McGlinchey T. Benchmarking: a useful tool for informing and improving care of the dying? Support Care Cancer. 2008;16(7):813-819.
8. Mercadante S., Intravaia G., Villari P., Ferrera P., David F., Casuccio A. Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage. 2009;37(5):771-779.
9. Mercadante S., Fulfaro F., Casuccio A., Barresi L. Investigation of an opioid response categorization in advanced cancer patients. J Pain Symptom Manage. 1999;18(5):347-352.
10. Mercadante S., Ferrera P., Villari P., Casuccio A. Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol. 2005;23(22):5229-5234.
11. Sykes N., Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol. 2003;4(5):312-318.
12. Schiessl C., Sittl R., Griessinger N., Lutter N., Schuettler J. Intravenous morphine consumption in outpatients with cancer during their last week of life-an analysis based on patient-controlled analgesia data. Support Care Cancer. 2008;16(8): 917-923.
13. Bercovitch M., Adunsky A. Patterns of high dose morphine use in a home-care hospice service. Should we be afraid of it? Cancer. 2004;101(6):1473-1437.
14. Chater S., Viola R., Paterson J. Jarvis V. Sedation for intractable distress in the dying-a survey of experts. Palliat Med. 1998; 12(4):255-269.
15. Good PD, Ravenscroft PJ, Cavenagh J. Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Intern Med J. 205;35(9):512-517.
16. Mercadante S., Intravaia G., Villari P., Ferrera P., David F., Casuccio A. Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage. 2009;37(5):771-779.
17. Kohara H., Ueoka H., Takeyama H., Murakami T., Morita T. Sedation for terminally ill patients with cancer with uncontrollable physical distress. J Palliat Med. 2005;8(1):20-25.
18. De Graeff A., Dean M. Palliative sedation therapy in the last weeks: a literature review and recommendations for standards. J Palliat Med. 2007;10(1):67-85.
19. Morita T., Chinone Y., Ikenaga M.,et al.Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. J Pain Sypmtom Manage. 2005; 30(4):320-328.
20. Miccinesi G., Rietjens J., Deliens L.,et al.Continuous deep sedation: physicians' experiences in six European countries. J Pain Symptom Manage. 2006;31(2):122-129.
21. Bielsen J., Norup M., Deliens L.,et al.Drugs used to alleviate symptoms with life shortening as a possible side effect: end-of-life care in six European countries. J Pain Symptom Manage. 2006;31(2):111-121.
22. Reuzel RPB, Hasselaar GJ, van der Wilt GJ, Groenewoud JMM, Crul BJP. Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study. Palliat Med. 2008;22(5):641-646.
23. Mercadante S., Intravaia G., Villari P.,et al.Clinical and financial analysis of an acute palliative care unit in an oncological department. Palliat Med. 2008;22(6):760-767.